Assessing Depression in a Geriatric Cancer Population

Active, not recruiting

• Conditions: Breast Cancer; Prostate Cancer

• Registration Number: NCT00580476
• Lead Sponsor: Memorial Sloan Kettering Cancer Center

Brief Summary

The goal of this study is to learn more about how we measure depression in elderly cancer patients (patients aged 70 and older). Depression is one of the most common causes of emotional distress in the elderly and continues to be under-recognized. This is a problem because depression can have a negative impact on quality of life. The symptoms of depression are linked to poor health outcomes and higher costs of health care. In fact, depression is one of the top five concerns facing the elderly today.

Detailed Description

We have a few questionnaires that have been used to measure depression, but we do not know how these measures work with people with cancer. This study will help us answer this question. To complete this study, we need people who may or may not be feeling down or depressed.

If you choose to take part, you will be asked to do the following:

1. Fill out questionnaires that ask about:

* Your age, eduction, race, and income

* Your mood

In all, these questionnaires will take about 10 minutes to complete.

2. Answer questions about your mood. This will also take about 10 minutes to complete.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2006-09
• Study First Submitted: 2007-12-19
• Study First Submitted QC: 2007-12-19
• Study First Posted: 2007-12-24
• Status Verified: 2024-01
• Last Update Submitted: 2024-01-12
• Last Update Posted: 2024-01-16
• Primary Completion: 2025-06-10
• Study Completion: 2025-06-10

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 201

Inclusion Criteria

1. Age 70 and older
2. Diagnosis of early or late stage prostate cancer, or diagnosis of early or late stage breast cancer
3. Actively engaged in one of the following cancer treatments: chemotherapy, radiation therapy, hormone therapy
4. Able to provide informed consent
5. Ability to converse, write and read English

Read More

Exclusion Criteria

1.Major psychopathology or cognitive impairment likely in the judgment of the research staff to interfere with the participation or completion of the protocol.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Test the sensitivity and specificity of the Geriatric Depression Scale-Short Form and two other widely used assessments of depression to detect major and minor depression in a geriatric breast and prostate cancer population.	2 years

Secondary Outcome Measures

Name	Time	Method
To develop a cut-off score for the GDS that is specific to a cancer population.	2 years

Trial Locations

Locations (1)

Memorial Sloan Kettering Cancer Center; 🇺🇸 New York, New York, United States